The first participants have taken part in a new research trial that aims to save lives by detecting lung cancer at an earlier stage when it is more treatable.
People attending the NHS Targeted Lung Health Checks in Southampton are being invited to take part in the iDx Lung trial, which will offer new types of tests to 10,000 people over the next 3 years.
Part-funded by Cancer Research UK, iDx Lung is a collaboration between the Cancer Research UK Southampton Clinical Trials Unit at the University of Southampton, the University of Leeds and healthcare and diagnostic companies.
The trial is currently taking place at the Royal South Hants Hospital, but in the autumn it will move to a mobile unit which can travel around the county with the NHS Targeted Lung Health Check vans.
Michelle Mitchell, chief executive of Cancer Research UK, said that lung cancer is a priority for the charity, as survival has improved very little over the last 40 years despite continuous research efforts.
“Trials have shown that CT scanning people at increased risk of developing the disease can reduce lung cancer deaths and combining CT screening with biomarker tests and using blood and nasal samples, it may help to catch more cases at an early stage of the disease, which can be easier to treat. We hope this will lead to more people surviving their lung cancer.”
Did you know lung disease costs the UK £11 billion every year?
Have a read at this???
Ibuprofen and Emphysema
Interesting research?
